| Resistant starch, microbiome, and precision modulation PA Dobranowski, A Stintzi Gut Microbes 13 (1), 1926842, 2021 | 89 | 2021 |
| Butyrate’s role in human health and the current progress towards its clinical application to treat gastrointestinal disease K Hodgkinson, F El Abbar, P Dobranowski, J Manoogian, J Butcher, ... Clinical Nutrition 42 (2), 61-75, 2023 | 72 | 2023 |
| Compositional changes to the ileal microbiome precede the onset of spontaneous ileitis in SHIP deficient mice PA Dobranowski, C Tang, JP Sauvé, SC Menzies, LM Sly Gut microbes 10 (5), 578-598, 2019 | 57 | 2019 |
| SHIP negatively regulates type II immune responses in mast cells and macrophages P Dobranowski, LM Sly Journal of leukocyte biology 103 (6), 1053-1064, 2018 | 19 | 2018 |
| Perspectives on the discovery of NOTCH2‐specific inhibitors P Dobranowski, F Ban, A Contreras‐Sanz, A Cherkasov, PC Black Chemical Biology & Drug Design 91 (3), 691-706, 2018 | 7 | 2018 |
| The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care H Mathias, N Rohatinsky, SK Murthy, K Novak, ME Kuenzig, GC Nguyen, ... Journal of the Canadian Association of Gastroenterology 6 (Supplement_2 …, 2023 | 4 | 2023 |
